Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers

Journal of Clinical Virology

Volumn 44, Issue 2, 2009, Pages 134-137

  Miedouge, Marcel ^a   Legrand Abravanel, Florence ^a   Lalanne, Colette ^a   Saune, Karine ^a   Izopet, Jacques ^a  

^a Institut Federatif de Biologie   (France)

Author keywords

Diagnosis; HBV; HCV; Immuno assay; Throughput; Virology

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANALYZER; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

CLINICAL LABORATORY TECHNIQUES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 59849124265     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.10.012     Document Type: Article

References (16)

1. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 11 (1996) 1019-1027
2. Ismail N., Fish G.E., and Smith M.B. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol 42 2 (2004 Feb) 610-617
3. Zachary P., Ullmann M., Djeddi S., Meyer N., Wendling M.J., Schvoerer E., et al. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. J Clin Virol 34 3 (2005) 207-210
4. Bland J.M. Measuring agreement in method comparison studies. Statis Methods Med 8 (1999) 135-160
5. Huzly D., Schenk T., Jilg W., and Neumann-Haefelin D. Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen. J Clin Microbiol 46 4 (2008) 1298-1306
6. Motte A., Colson P., and Tamalet C. Evaluation of the clinical performance of the Beckman Coulter Access AbHBsII immunoassay for the detection of hepatitis B surface antibodies. J Clin Virol 37 3 (2006) 213-217
7. Commission decision on common technical specifications for in vitro diagnostic medical devices. Off J Eur Commun 2002;L131:17-30.
8. Dati F., Denoyel G., and van Helden J. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. J Clin Virol 30 Suppl. 1 (2004) S6-S10
9. van Helden J., and Denoyel G.A. Experience with the IVDD performance evaluations of the ADVIA Centaur infectious disease assays. J Clin Virol 30 Suppl. 1 (2004) S16-S18
10. Jonas G., Pelzer C., Beckert C., Hausmann M., and Kapprell H.P. Performance characteristics of the ARCHITECT anti-HCV assay. J Clin Virol 34 2 (2005) 97-103
11. Huisman W., Horvath A.R., Burnett D., Blaton V., Czikkely R., Jansen R.T., et al. Accreditation of medical laboratories in the European Union. Clin Chem Lab Med 45 2 (2007) 268-275
12. Di Paolo D., Tisone G., Piccolo P., Lenci I., Zazza S., and Angelico M. Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. Transplantation 77 8 (2004) 1203-1208
13. Dimech W., Panagiotopoulos L., Francis B., Laven N., Marler J., Dickeson D., et al. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol. 46 6 (2008) 1955-1960 [epub 2008 April 23]
14. Heijtink R.A., Schneeberger P.M., Postma B., and Crombach W. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable. Vaccine 20 23-24 (2002) 2899-2905
15. Hendriks H.A., Kortlandt W., and Verweij W.M. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin Chem 46 1 (2000) 105-111
16. Taylor P., Pickard G., Gammie A., and Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J Clin Virol 30 Suppl. 1 (2004) S11-S15